Indefinite Delivery Contract SPE2DR25D9831

The key details of this federal contract IDV award are as follows:

This is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 that was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract is part of the DLA's Pharmaceutical Prime Vendor Global Program (PPV-G) Generation V, which aims to establish prime vendor contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, US Coast Guard, and US Naval Fleet. The contract has a 30-month base period with three 30-month option periods, for a total potential period of performance through December 2036.

The contract covers a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various dosage forms such as injections, tablets, creams, auto-injectors, and specialty medications. This IDC enables the DLA to issue firm fixed-price delivery orders to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. There is no set-aside designation for this procurement, which is being competitively awarded on a lowest price technically acceptable basis.